Campion Asset Management’s Amgen AMGN Stock Holding History

Campion Asset Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$581K	Sell	1,650 -114	-6%	-$40.6K	0.39%	37
2025 Q4	$577K	Sell	1,764 -5	-0.3%	-$1.59K	0.4%	36
2025 Q3	$499K	Sell	1,769 -30	-2%	-$8.7K	0.35%	50
2025 Q2	$502K	Sell	1,799 -69	-4%	-$19.5K	0.38%	44
2025 Q1	$582K	Hold	1,868	–	–	0.45%	40
2024 Q4	$487K	Hold	1,868	–	–	0.37%	48
2024 Q3	$602K	Sell	1,868 -32	-2%	-$10.5K	0.44%	40
2024 Q2	$594K	Hold	1,900	–	–	0.47%	38
2024 Q1	$540K	Hold	1,900	–	–	0.42%	51
2023 Q4	$547K	Hold	1,900	–	–	0.46%	46
2023 Q3	$511K	Hold	1,900	–	–	0.47%	45
2023 Q2	$422K	Buy	1,900 +285	+18%	+$66.1K	0.38%	57
2023 Q1	$390K	Hold	1,615	–	–	0.37%	60
2022 Q4	$424K	Hold	1,615	–	–	0.42%	52
2022 Q3	$364K	Hold	1,615	–	–	0.38%	57
2022 Q2	$393K	Hold	1,615	–	–	0.39%	55
2022 Q1	$391K	Hold	1,615	–	–	0.33%	63
2021 Q4	$363K	Hold	1,615	–	–	0.3%	68
2021 Q3	$343K	Hold	1,615	–	–	0.31%	68
2021 Q2	$394K	Sell	1,615 -680	-30%	-$167K	0.33%	60
2021 Q1	$571K	Buy	+2,295	New	+$548K	0.43%	42

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Campion Asset Management's AMGN Position: Q1 2026 in Review

Campion Asset Management reduced its Amgen (AMGN) stake by 6.5% in Q1 2026, selling an estimated $40.6K and leaving 1,650 shares worth $581K. The position accounts for 0.39% of the portfolio, ranked #37.

Campion Asset Management first reported a position in AMGN in Q1 2021 and has held it in 21 quarters since. The position peaked at $602K in Q3 2024. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Campion Asset Management held 1,650 shares of Amgen worth $581K as of Q1 2026.
Campion Asset Management sold 114 Amgen shares in Q1 2026, an estimated $40.6K.
Amgen made up 0.39% of Campion Asset Management's portfolio in Q1 2026, its #37 holding.
Campion Asset Management first reported a position in Amgen in Q1 2021 and has held it in 21 quarters since.
Campion Asset Management's Amgen position peaked at $602K in Q3 2024.
3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Campion Asset Management's 13F filing for Q1 2026, filed 14 May 2026.